From October 1, 2023 to December 31, 2023, the company has repurchased 220,300 shares, representing 0.02% for CNY 4.25 million. With this, the company has completed the repurchase of 220,300 shares, representing 0.02% for CNY 4.25 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.13 CNY | +1.68% | +2.51% | +15.12% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.12% | 6.72B | |
+15.45% | 8.39B | |
+3.59% | 7.58B | |
-5.87% | 3.73B | |
+5.27% | 1.44B | |
-30.41% | 1.03B | |
+21.35% | 1.03B | |
-13.62% | 858M | |
-18.91% | 785M | |
+1.92% | 727M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.